Back to AVBP
UBS Group AG AVBP Position History
ArriVent BioPharma, Inc. • Healthcare
Quarters held
7
Latest value
$198K
Q3 2026
Peak value
$16.2M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $9.2M |
| Q4 2025 | $9.1M |
| Q4 2025 | $7K |
| Q1 2026 | $11.2M |
| Q2 2026 | $15.2M |
| Q3 2026 | $16.2M |
| Q3 2026 | $198K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $198K | 6.5K | — | — |
| Q3 2026 | $16.2M | 535.0K | — | — |
| Q2 2026 | $15.2M | 438.6K | — | — |
| Q1 2026 | $11.2M | 486.3K | — | — |
| Q4 2025 | $7K | 333 | — | — |
| Q4 2025 | $9.1M | 450.6K | — | — |
| Q3 2025 | $9.2M | 497.6K | — | — |
Other funds holding AVBP
$156.9M
$149.1M
$136.5M
$119M
$105.2M
$101.5M